CHROMOCELL CORPORATION
Selective Nav1.8 sodium channel blockers (small molecule analgesic compounds) for post-surgical pain and inflammation
- Sector
- Biotech
- Headquarters
- North Brunswick, NJ
- Total capital
- $225K
- Federal grants
- $225K
- 1 award · 2019
- Rank in peer group#317 of 392
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 35 pending · first 2016
- Rank in peer group#25 of 392
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · The use of selective NaV1.7 inhibitors to treat inflammation post-surgery$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#25 · top 6%
- Linked publications#5 · top 1%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 5 granted of 40- PendingCell Engineering Compositions And Methods Using Fluorogenic Oligonucleotide Signaling Probes And Flow CytometryUSPTOApplication 18261606
- PendingCompositions With Sugar Like CharacteristicsUSPTOApplication 17618570
- PendingCompounds, Compositions, And Methods For Modulating Sweet TasteUSPTOApplication 16317745
Show all 40 patent records
- Cell Engineering Compositions And Methods Using Fluorogenic Oligonucleotide Signaling Probes And Flow CytometryApr 11, 2024 · Application 18261606Pending
- Compositions With Sugar Like CharacteristicsAug 18, 2022 · Application 17618570Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteSep 16, 2021 · Application 16317745Pending
- Tryptophan Derivatives As SweetenersSep 24, 2020 · Application 16895378Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteSep 10, 2019 · US 10,407,400Granted
- Sodium Channel Modulators For The Treatment Of PainJan 15, 2019 · US 10,179,781Granted
- Assays For Identifying Compounds That Modulate Bitter TasteMar 27, 2018 · US 9,927,424Granted
- SELECTIVE NaV1.7 INHIBITORS FOR THE TREATMENT OF DIABETESOct 26, 2017 · Application 15510047Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteOct 26, 2017 · Application 15507468Pending
- CELL LINES EXPRESSING NaV AND METHODS OF USING THEMAug 3, 2017 · Application 15000974Pending
- Compounds, Compositions, And Methods For Reducing Or Eliminating Bitter TasteJul 6, 2017 · Application 15308711Pending
- Methods and Compositions for Identifying and Validating Modulators of Cell FateMay 23, 2017 · US 9,657,357Granted
- Novel Cell Lines And MethodsFeb 23, 2017 · Application 15231202Pending
- Cell Lines And Methods For Making And Using ThemOct 20, 2016 · Application 15077747Pending
- Sodium Channel Modulators For The Treatment Of Pain And DiabetesOct 4, 2016 · US 9,458,118Granted
- NOVEL CELL LINES EXPRESSING ENaC and METHODS USING THEMAug 18, 2016 · Application 14946582Pending
- Sodium Channel Modulators For The Treatment Of Pain And DiabetesAug 4, 2016 · Application 15021153Pending
- Methods And Materials Using Signaling ProbesMay 5, 2016 · Application 14776695Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteJan 21, 2016 · Application 14775093Pending
- Cell Lines Expressing Cftr And Methods Of Using ThemNov 5, 2015 · Application 14552192Pending
- Methods And Materials Using Signaling ProbesOct 22, 2015 · Application 14534896Pending
- NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEMSep 10, 2015 · Application 14516391Pending
- Isolation Of Living Cells And Preparation Of Cell Lines Based On Detection And Quantification Of Preselected Cellular Ribonucleic Acid SequencesMay 21, 2015 · Application 14599319Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteFeb 19, 2015 · Application 14211895Pending
- Methods And Materials Using Signaling ProbesDec 5, 2013 · Application 13839685Pending
- Compounds and methods of using compounds for the prevention or treatment of inflammatory conditionsApplication 62670072Pending
- Tryptophan Derivatives As SweetenersApplication PCTUS2018064473Pending
- Compounds Compositions And Methods For Modulating Salty TasteApplication PCTUS2019013289Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteApplication PCTUS2016013296Pending
- Compounds And Methods Of Using Compounds For The Prevention Or Treatment Of Peripheral Nerve DamageApplication PCTUS2019027424Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteApplication PCTUS2016013269Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteApplication 62258931Pending
- Compounds And Methods Of Using Compounds For The Prevention Or Treatment Of Inflammatory ConditionsApplication PCTUS2019031729Pending
- Compounds And Methods Of Using Compounds For Treatment Of Respiratory DiseasesApplication 63036165Pending
- Compositions With Sugar Like CharacteristicsApplication PCTUS2020036779Pending
- Cell Engineering Compositions And Methods Using Fluorogenic Oligonucleotide Signaling Probes And Flow CytometryApplication 63138257Pending
- SELECTIVE NaV1.7 INHIBITORS FOR THE TREATMENT OF DIABETESApplication PCTUS2015048927Pending
- Compounds, Compositions, And Methods For Modulating Sweet TasteApplication PCTUS2015048400Pending
- Compounds, Compositions, And Methods For Reducing Or Eliminating Bitter TasteApplication PCTUS2015029770Pending
- Cell Engineering Compositions And Methods Using Fluorogenic Oligonucleotide Signaling Probes And Flow CytometryApplication PCTUS2022012533Pending
Recent research by its founders
- Study of the physicochemical and biological properties of Fucus vesiculosus polysaccharides20261 cites
- Academician of the Russian Academy of Sciences Alexander Yu. Prosekov: On His 50 th Birthday20260 cites
- Assessment of the Biotechnological Potential of Cyanobacteria from the Calu Collection: Influence of Strain and Cultivation Conditions20260 cites
Related companies, and why
- CytokineticsSimilar federal contract value in Biotech · null in contracts
- CurlBio LLCSimilar federal contract value in Biotech · null in contracts
- DMK PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- DISCOVERYBIOMED, INC.Similar federal contract value in Biotech · null in contracts
- PHOENICIA BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- REVEL TECHNOLOGIES, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .